Xenetic Biosciences Competitors and Similar CompaniesClear all

Xenetic Biosciences's competitors and similar companies include Shenzhen TargetRx, Apexigen, Kintor and CG Oncology.

	Xenetic Biosciences Xenetic Biosciences is a biopharmaceutical company developing next-generation biologic drugs and novel oncology therapeutics.	Shenzhen TargetRx Shenzhen TargetRx is a pharmaceutical research and development company.	Apexigen Apexigen is a company that develops antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology.	Kintor Kintor is a company that discovers cancer treatment solutions.	CG Oncology CG Oncology (formerly known as Cold Genesys) is an oncolytic immunotherapy company.
Founding Date	Founding Date 2011	Founding Date 2014	Founding Date 2010	Founding Date 2009	Founding Date 2010
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare drug development healthtech oncology pharma	Tags Healthcare drug development healthtech oncology pharma	Tags Healthcare biotech drug development healthtech oncology pharma	Tags Healthcare drug development healthtech oncology pharma	Tags Healthcare biotech drug development healthtech oncology pharma
Locations	Locations Framingham, US HQ Boston, US Henderson, US	Locations Shenzhen Shi, CN HQ	Locations San Carlos, US HQ	Locations Suzhou Shi, CN HQ	Locations Irvine, US HQ Emeryville, US
Employees	Employees 420% decrease	Employees N/A	Employees 10	Employees N/A	Employees 14226% increase
Valuation ($)	Valuation ($) 5.7 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 2.5 b
Financial
Revenue (est.)	Revenue (est.) $3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $4m (FY, 2025)
Net income	Net income ($2.7m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ($161m) (FY, 2025)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 21.2m (about 6 years ago)	Latest funding round $ 65m (about 6 years ago)	Latest funding round $ 45m (over 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 10m	Total funding raised $ 24.1m	Total funding raised $ 158m	Total funding raised $ 99m	Total funding raised $ 92.6m